Analysts Update Their Price Forecasts For FibroGen Inc (FGEN)

FibroGen Inc (FGEN) concluded trading on Wednesday at a closing price of $1.47, with 10.32 million shares of worth about $15.17 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 81.48% during that period and on April 3, 2024 the price saw a loss of about -31.94%. Currently the company’s common shares owned by public are about 98.77M shares, out of which, 91.83M shares are available for trading.

Stock saw a price change of -39.75% in past 5 days and over the past one month there was a price change of -25.76%. Year-to-date (YTD), FGEN shares are showing a performance of 65.86% which decreased to -92.12% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.33 but also hit the highest price of $20.90 during that period. The average intraday trading volume for FibroGen Inc shares is 2.61 million. The stock is currently trading -32.55% below its 20-day simple moving average (SMA20), while that difference is down -26.01% for SMA50 and it goes to -18.28% lower than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

FibroGen Inc (NASDAQ: FGEN) currently have 98.77M outstanding shares and institutions hold larger chunk of about 71.23% of that.

The stock has a current market capitalization of $145.19M and its 3Y-monthly beta is at 0.74. It has posted earnings per share of -$2.93 in the same period. It has Quick Ratio of 1.33. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for FGEN, volatility over the week remained 26.45% while standing at 15.51% over the month.

Analysts are in expectations that FibroGen Inc (FGEN) stock would likely to be making an EPS of -$0.41 in the current quarter, while forecast for next quarter EPS is -$0.4 and it is -$0.43 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.52 which is -$0.31 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.81 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 55.68% while it is estimated to increase by 66.87% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BofA Securities on August 08, 2023 offering an Underperform rating for the stock and assigned a target price range of between $4 and $2 to it. Stock get a Neutral rating from BofA Securities on June 26, 2023.

Most Popular

Related Posts